Infectious Disorders - Drug Targets
Title: Editorial [Hot Topic: New Advances in Intensive Care Unit-Acquired Infection (Guest Editor: Saad Nseir)]
Volume: 11 Issue: 4
Author(s): Saad Nseir and Alain Durocher
Affiliation:
Export Options
About this article
Cite this article as:
Nseir Saad and Durocher Alain, Editorial [Hot Topic: New Advances in Intensive Care Unit-Acquired Infection (Guest Editor: Saad Nseir)], Infectious Disorders - Drug Targets 2011; 11 (4) . https://dx.doi.org/10.2174/187152611796504809
DOI https://dx.doi.org/10.2174/187152611796504809 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
9
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Immunoproteasome: An Emerging Therapeutic Target
Current Topics in Medicinal Chemistry Lymphocytic Choriomeningitis Virus Infection: Neglected Teratogenic Zoonosis
Current Women`s Health Reviews Mosquito and Tick-borne Illnesses in the United States. Guidelines for the Recognition and Empiric Treatment of Zoonotic Diseases in the Wilderness.
Infectious Disorders - Drug Targets Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches
Current Pharmaceutical Biotechnology Adenosine Dysfunction in Epilepsy and Associated Comorbidities
Current Drug Targets Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism The Microbiota and Gut-Brain Axis: Contributions to the Immunopathogenesis of Schizophrenia
Current Pharmaceutical Design Editorial: [Hot Topic HIV and Substance Abuse]
Current HIV Research Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
CNS & Neurological Disorders - Drug Targets The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology HIV-1 Tat Protein Exposure Potentiates Ethanol Reward and Reinstates Extinguished Ethanol-Conditioned Place Preference
Current HIV Research Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Virus-Based RNA Silencing Agents and Virus-Derived Expression Vectors as Gene Therapy Vehicles
Recent Patents on Biotechnology HIV-1 Capsid Inhibitors as Antiretroviral Agents
Current HIV Research Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Characterizing the Zika Virus Genome – A Bioinformatics Study
Current Computer-Aided Drug Design Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis
Infectious Disorders - Drug Targets In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases
Current Drug Metabolism Novel Opportunities to Study and Block Interactions between Viruses and Cell Surface Heparan Sulfates by using Dispirotripiperazines
Letters in Drug Design & Discovery